A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse Gastrointestinal Cancer Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me